| 摘要 |
The present invention relates to new compounds of the formula (I) wherein Y, X, P, Q, R1, R2, R3, R4, R5A, R6, R7, R8, R9, A, B, n, m are defined as in claim 1, a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds for the treatment of conditions associated with glycogen synthase kinase-3 (GSK3) as well as an intermediate used in the preparation of said compounds.
|
